Cardiology Today -- Patients who experienced sirolimus-eluting stent restenosis had similar outcomes after treatment with either repeat sirolimus-eluting stent implantation or a switch to paclitaxel-eluting stent, results from the ISAR-DESIRE 2 trial indicated.
